Long-term outcomes of two-stage revision with positive cultures at reimplantation - Scorecard - MDSpire

Long-term outcomes of two-stage revision with positive cultures at reimplantation

  • By

  • Caterina Rocchi

  • Carmine Fabio Bruno

  • Rocco Cannata

  • Katia Chiappetta

  • Guido Grappiolo

  • Mattia Loppini

  • February 26, 2026

  • 0 min

Share

Clinical Scorecard: Outcomes of Two-Stage Revision Surgery with Positive Cultures During Reimplantation: A Long-Term Analysis

At a Glance

CategoryDetail
ConditionPeriprosthetic Joint Infection (PJI) following Total Joint Arthroplasty (TJA)
Key MechanismsTwo-stage revision surgery involving removal of infected prosthesis, antibiotic-loaded spacer placement, systemic antibiotics, and reimplantation after infection resolution; positive cultures at reimplantation may indicate persistent infection
Target PopulationPatients undergoing two-stage revision for hip and knee PJIs
Care SettingHigh-volume orthopedic referral center with surgical and microbiological facilities

Key Highlights

  • PJI affects approximately 2% of TJA patients and is a major cause of revision surgery with significant healthcare costs.
  • Two-stage revision is standard for critical PJI cases, involving explantation, antibiotic spacer, and delayed reimplantation.
  • Positive cultures at reimplantation occur in 15-30% of cases and their prognostic significance remains controversial.

Guideline-Based Recommendations

Diagnosis

  • Use Musculoskeletal Infection Society (MSIS) 2013 criteria for PJI diagnosis.
  • Obtain multiple intraoperative samples (5–7 biopsies) from periprosthetic tissue, synovial fluid, and prosthesis sonicate for microbiological analysis.
  • Include cultures for aerobic, anaerobic bacteria, and filamentous fungi with prolonged incubation (14 days).

Management

  • Perform two-stage revision surgery with removal of infected prosthesis and placement of antibiotic-loaded spacer.
  • Administer empirical antibiotics post-explant surgery, then tailor regimen based on culture results.
  • Confirm infection resolution by normalized serum C-reactive protein (<0.5 mg/dL) in three consecutive measurements before reimplantation.
  • Observe a 12-day antibiotic washout period prior to sample collection at reimplantation.

Monitoring & Follow-up

  • Monitor serum C-reactive protein levels to assess infection resolution.
  • Evaluate patients clinically and microbiologically before reimplantation.
  • Consider patient factors such as age, ASA score ≥ III, and McPherson host type C for risk stratification.

Risks

  • Positive cultures at reimplantation may indicate persistent infection and are associated with higher risk of treatment failure.
  • Certain pathogens (Gram-negative bacteria, streptococci, polymicrobial, resistant organisms) correlate with higher failure and mortality rates.
  • Patient-related factors (older age, higher ASA score, host type C) contribute to poorer outcomes and risk of re-revision.

Patient & Prescribing Data

Patients undergoing two-stage revision for hip and knee PJIs with available histological and microbiological data

Empirical antibiotic therapy initiated post-explant and adjusted per culture results; no preoperative prophylaxis before reimplantation; antibiotic washout period observed to improve culture accuracy

Clinical Best Practices

  • Use multiple and varied intraoperative samples to improve microbiological detection and distinguish contamination from true infection.
  • Tailor antibiotic therapy based on pathogen identification and sensitivity.
  • Apply a patient-specific approach considering comorbidities and host status when interpreting positive cultures at reimplantation.
  • Ensure mechanical stability of spacers (e.g., proximal neck cementation for hip spacers) to facilitate removal and maintain function.
  • Employ articulated spacers (Hoffman technique) in knees with preserved bone stock and stable ligaments to allow joint motion during interval.

References

Original Source(s)

Related Content